The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS

Omar Alkharabsheh; Aref Al-Kali; Salwa Saadeh; Rong He; David Viswanatha; Patricia Greipp; Kaaren Reichard; Mithun Shah; Naseema Gangat; Mrinal Patnaik; William Hogan; Mark Litzow; Hassan Alkhateeb; Phuong L. Nguyen

doi:10.1002/ajh.25239

The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS

Omar Alkharabsheh, Aref Al-Kali, Salwa Saadeh, Rong He, David Viswanatha, Patricia Greipp, Kaaren Reichard, Mithun Shah, Naseema Gangat, Mrinal Patnaik, William Hogan, Mark Litzow, Hassan Alkhateeb, Phuong L. Nguyen

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	E355-E357
Journal	American journal of hematology
Volume	93
Issue number	11
DOIs	https://doi.org/10.1002/ajh.25239
State	Published - Nov 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.25239

Cite this

Alkharabsheh, O., Al-Kali, A., Saadeh, S., He, R., Viswanatha, D., Greipp, P., Reichard, K., Shah, M., Gangat, N., Patnaik, M., Hogan, W., Litzow, M., Alkhateeb, H., & Nguyen, P. L. (2018). The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS. American journal of hematology, 93(11), E355-E357. https://doi.org/10.1002/ajh.25239

Alkharabsheh, O, Al-Kali, A, Saadeh, S, He, R, Viswanatha, D, Greipp, P, Reichard, K, Shah, M, Gangat, N, Patnaik, M , Hogan, W , Litzow, M, Alkhateeb, H & Nguyen, PL 2018, 'The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS', American journal of hematology, vol. 93, no. 11, pp. E355-E357. https://doi.org/10.1002/ajh.25239

@article{3ace8410606a49bc8d77734b41fbeb06,

title = "The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS",

author = "Omar Alkharabsheh and Aref Al-Kali and Salwa Saadeh and Rong He and David Viswanatha and Patricia Greipp and Kaaren Reichard and Mithun Shah and Naseema Gangat and Mrinal Patnaik and William Hogan and Mark Litzow and Hassan Alkhateeb and Nguyen, {Phuong L.}",

year = "2018",

month = nov,

doi = "10.1002/ajh.25239",

language = "English (US)",

volume = "93",

pages = "E355--E357",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "11",

}

TY - JOUR

T1 - The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS

AU - Alkharabsheh, Omar

AU - Al-Kali, Aref

AU - Saadeh, Salwa

AU - He, Rong

AU - Viswanatha, David

AU - Greipp, Patricia

AU - Reichard, Kaaren

AU - Shah, Mithun

AU - Gangat, Naseema

AU - Patnaik, Mrinal

AU - Hogan, William

AU - Litzow, Mark

AU - Alkhateeb, Hassan

AU - Nguyen, Phuong L.

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85054340309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054340309&partnerID=8YFLogxK

U2 - 10.1002/ajh.25239

DO - 10.1002/ajh.25239

M3 - Letter

C2 - 30074268

AN - SCOPUS:85054340309

SN - 0361-8609

VL - 93

SP - E355-E357

JO - American journal of hematology

JF - American journal of hematology

IS - 11

ER -

The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this